Literature DB >> 7615270

A population based study of Helicobacter pylori infection in a European country: the San Marino Study. Relations with gastrointestinal diseases.

G Gasbarrini1, S Pretolani, F Bonvicini, M R Gatto, E Tonelli, F Mégraud, K Mayo, G Ghironzi, G Giulianelli, M Grassi.   

Abstract

Helicobacter pylori is present worldwide but few large population studies exist on the epidemiology of the infection. A random cross sectional study was performed of H pylori infection in the adult population of San Marino, a European country with high gastric cancer rate, to assess its prevalence and to evaluate its relations with gastrointestinal disease. In 2237 subjects (77% of the initial sample) H pylori IgG antibodies were detected with enzyme linked immunosorbent assay (ELISA) and immunoblotting. A questionnaire including questions about occupation, place of birth, and smoking was given to all subjects. Dyspepsia, peptic ulcer, and gastric cancer in the subjects, relatives, and partners as well as use of drug, dental treatment/prostheses, and gastrointestinal endoscopies, were evaluated by multivariate analysis. H pylori prevalence was of 51%, increased with age from 23% (20-29 years) to 68% (> or = 70 years), and was higher among manual workers. H pylori was independently associated with ulcer (OR = 1.63, 95% confidence intervals (CI) = 1.16 to 2.27), H2 antagonists (OR = 1.94, 95% CI = 1.21 to 3.10), and benzodiazepines (OR = 1.57, 95% CI = 1.02 to 2.42), dental prostheses (OR = 1.25, 95% CI = 1.05 to 1.49), gastroscopy in the past five years (OR = 1.50, 95% CI = 1.05 to 2.14), peptic ulcer in siblings (OR = 1.52, 95% CI = 1.09 to 2.12), gastric cancer in father (OR = 1.61, 95% CI = 1.02 to 2.52). The association of seropositivity with history of ulcer, gastric cancer in family, gastroscopy, and H2 antagonists suggests that H pylori is an epidemiological key factor in the pathogenesis of gastroduodenal diseases in this area.

Entities:  

Mesh:

Year:  1995        PMID: 7615270      PMCID: PMC1382619          DOI: 10.1136/gut.36.6.838

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  36 in total

1.  Increased incidence of Campylobacter pylori infection in gastroenterologists: further evidence to support person-to-person transmission of C. pylori.

Authors:  H M Mitchell; A Lee; J Carrick
Journal:  Scand J Gastroenterol       Date:  1989-05       Impact factor: 2.423

2.  [Titration of anti-Campylobacter pylori by ELISA].

Authors:  M P Rabbé; F Mégraud
Journal:  Gastroenterol Clin Biol       Date:  1988 Jun-Jul

3.  Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random.

Authors:  M Siurala; M Isokoski; K Varis; M Kekki
Journal:  Scand J Gastroenterol       Date:  1968       Impact factor: 2.423

4.  Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.

Authors:  D Y Graham; G M Lew; P D Klein; D G Evans; D J Evans; Z A Saeed; H M Malaty
Journal:  Ann Intern Med       Date:  1992-05-01       Impact factor: 25.391

5.  Seroepidemiology of Campylobacter pylori infection in various populations.

Authors:  F Mégraud; M P Brassens-Rabbé; F Denis; A Belbouri; D Q Hoa
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

6.  Association of anxiety, neuroticism, and depression with dyspepsia of unknown cause. A case-control study.

Authors:  N J Talley; L H Fung; I J Gilligan; D McNeil; D W Piper
Journal:  Gastroenterology       Date:  1986-04       Impact factor: 22.682

7.  Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data.

Authors:  P Sipponen; M Kekki; J Haapakoski; T Ihamäki; M Siurala
Journal:  Int J Cancer       Date:  1985-02-15       Impact factor: 7.396

8.  Gastric cancer in San Marinese and their first degree relatives in San Marino and the United States. Gastroscopic biopsy as an epidemiological tool.

Authors:  B M Schuman; P Salerno-Mele; G Ghironzi; C E Jackson; C K Ma; G Spigolon
Journal:  Gastrointest Endosc       Date:  1987-06       Impact factor: 9.427

9.  Campylobacter pylori-associated gastritis and immune response in a population at increased risk of gastric carcinoma.

Authors:  J G Fox; P Correa; N S Taylor; D Zavala; E Fontham; F Janney; E Rodriguez; F Hunter; S Diavolitsis
Journal:  Am J Gastroenterol       Date:  1989-07       Impact factor: 10.864

10.  Cancer mortality in Italy: an overview of age-specific and age-standardised trends from 1955 to 1984.

Authors:  C La Vecchia; E Negri; A Decarli; M Fasoli; C Cislaghi
Journal:  Tumori       Date:  1990-04-30
View more
  21 in total

Review 1.  How should Helicobacter pylori negative patients be managed?

Authors:  V Stanghellini; C Tosetti; R De Giorgio; G Barbara; B Salvioli; R Corinaldesi
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

2.  Heterogeneity of immunoglobulin G response to Helicobacter pylori measured by the unweighted pair group method with averages.

Authors:  K Mayo; S Pretolani; G Gasbarrini; G Ghironzi; F Megraud
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

3.  Population-based survey of hepatitis A virus infection in the Republic of San Marino.

Authors:  T Stroffolini; S Pretolani; F Miglio; M Rapicetta; U Villano; F Bonvicini; L Baldini; F Sampogna; G Giulianelli; M L Stefanelli; A Carloni; A Sorcinelli; G Ghironzi; G Gasbarrini
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

Review 4.  Prevalence of Helicobacter pylori infection worldwide: a systematic review of studies with national coverage.

Authors:  Bárbara Peleteiro; Ana Bastos; Ana Ferro; Nuno Lunet
Journal:  Dig Dis Sci       Date:  2014-02-22       Impact factor: 3.199

5.  Prevalence of virulent Helicobacter pylori strains in patients affected by idiopathic dysrhythmias.

Authors:  Francesco Franceschi; Donatella Brisinda; Francesco Buccelletti; Maria Pia Ruggieri; Antonio Gasbarrini; Annarita Sorbo; Davide Marsiliani; Angela Venuti; Peter Fenici; Giovanni Gasbarrini; Nicolò Gentiloni Silveri; Riccardo Fenici
Journal:  Intern Emerg Med       Date:  2011-05-12       Impact factor: 3.397

6.  Helicobacter pylori in dental plaque and stomach of patients from Northern Brazil.

Authors:  Mônica Baraúna Assumpção; Luisa Caricio Martins; Hivana Patricia Melo Barbosa; Katarine Antonia dos Santos Barile; Sintia Silva de Almeida; Paulo Pimentel Assumpção; Tereza Cristina de Oliveira Corvelo
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

7.  Helicobacter pylori infection: a seroepidemiological study in Gipuzkoa, Basque Country, Spain.

Authors:  G Cilla; E Pérez-Trallero; M García-Bengoechea; J M Marimón; J I Arenas
Journal:  Eur J Epidemiol       Date:  1997-12       Impact factor: 8.082

8.  Community-based familial study of Helicobacter pylori infection among healthy Japanese Brazilians.

Authors:  Lucy S Ito; Sueli M Oba-Shinjo; Samuel K Shinjo; Miyuki Uno; Suely K N Marie; Nobuyuki Hamajima
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

9.  Helicobacter pylori eradication ameliorates primary Raynaud's phenomenon.

Authors:  A Gasbarrini; I Massari; M Serricchio; P Tondi; A De Luca; F Franceschi; V Ojetti; A Dal Lago; R Flore; A Santoliquido; G Gasbarrini; P Pola
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

Review 10.  Helicobacter pylori infection and inflammatory bowel disease in Asians: a meta-analysis.

Authors:  Xiao-Wei Wu; Hong-Zan Ji; Miao-Fang Yang; Lin Wu; Fang-Yu Wang
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.